Microencapsulation of rh-erythropoietin, using biodegradable poly(D,L- lactide-co-glycolide): Protein stability and the effects of stabilizing excipients

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 43, Issue 1, 1997, Pages 29-36

  Morlock, Michael ^a   Koll, Hans ^b   Winter, Gerhard ^b   Kissel, Thomas ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Erythropoietin; Excipients; Microspheres; Parenteral depot systems; Poly(D,L lactide co glycolide); Protein stability

Indexed keywords

POLYGLACTIN; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG STABILITY; GEL PERMEATION CHROMATOGRAPHY; MICROEMULSION; MICROENCAPSULATION; PROTEIN STABILITY;

EID: 0031398790     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(96)00017-3     Document Type: Article

References (34)

1. Krantz SB. Erythropoietin, Blood 1991;77:419-34.
2. Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N. Engl. J. Med. 1989;321:158-63.
3. Nahri L, Arakawa T, Aoki KH et al. The effect of carbohydrate on the structure and stability of erythropoietin. J. Biol. Chem. 1991;266:23022-26.
4. Pitt CG. The controlled parenteral delivery of polypeptides and proteins. Int. J. Pharm. 1990;59:173-96.
5. Sanders LM, Kent JS, McRae GI, Vickery BH, Tice TR, Lewis DH. Controlled release of a luteinizing hormone-releasing hormone analkogue from poly (D,L-lactide-co-glycolide microspheres. J. Pharm. Sci. 1984;73:1294-7.
6. Ogawa Y, Yamamoto M, Okada H, Yashiki T, Shimamoto T. Technique to efficiently entrap Leuprolide actetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. Chem. Pharm. Bull. 1988;36:1095-103.
7. Hora MS, Rana RK, Nunberg JH, Tice TR, Gilley RM, Hudson ME. Controlled release of Interleukin-2 from biodegradable microspheres. Biotechnology 1990;8:755-8.
8. Eppstein DA, Kurahara CG, Bruno NA, Van der Par MA, Marsh JV, Schryver BB. Pathways to increasing efficacy of interferon drug synergy and sustained release. Biol. Interferon Syst. Proceed. 1985:401-9.
9. Wang YJ, Hanson M. Parenteral formulations of proteins and peptides: Stability and stabilizers. J. Parenteral Sci. Tech. 1988;42:1-26.
10. Bodmer D, Kissel T, Traechslin E. Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems. J. Control. Release 1992;21:129-38.
11. Bawa R, Siegel RA, Marasca B, Karel M, Langer R. An explanation for the controlled release of macromolecules from polymers. J. Control. Release 1985;1:259-67.
12. Cohen S, Yoshioka T, Lucarelli M, Hwang LH, Langer R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res. 1991;8:713-20.
13. Manning MC, Patel K, Borchardt RT. Stability of Protein Pharmaceuticals. Pharm. Res. 1989;6:903-18.
14. DePaolis AM, Advanti JV, Shrama BG. Characterization of erythropoietin dimerization. J. Pharm. Sci. 1995;84:1280-4.
15. Charman SA, Mason KL, Charman WN. Techniques for assessing the effects of pharmaceutical aggregation excipients on the aggregation of porcine growth hormone. Pharm. Res. 1993;10:954-62.
16. Tabata Y, Takebayashi Y, Ueda T, Ikada Y, A formulation method using D,L-lactic acid oligomer for protein release with reduced initial burst. J. Control. Release 1993;23:55-64.
17. Constantino HR, Langer R, Klibanov AM. Moisture-induced aggregation of lyophilized insulin. Pharm. Res. 1994;11:21-9.
18. Liu WR, Langer R, Klibanov AM. Moisture-Induced Aggregation of Lyophilized Proteins in the Solid State. Biotechnol. Bioeng. 1991;37:177-84.
19. Morlock M. Erythropoietin microparticles: An investigation of the microencapsulation of proteins using biodegradable polyesters. PhD Thesis, University of Marburg, Germany, 1995.
20. Hoffman A, Nyska A, Avramoff A, Golomb G. Continuous versus pulsatile administration of erythropoietin (EPO) via the uterus of anemic rats. Int. J. Pharm. 1995;117:197-202.
21. Bernstein H, Mathiowitz E, Morrel E, Brickner A. Erythropoietin drug delivery system. PCT 93/25221 (23.12.93).
22. Jeffery H, Davis SS, O'Hagan DT. The preparation and characterization of poly(lactide-co-glycolide) microparticles II: the entrapment of a model protein, using (Water-in-oil)-in-water emulsion solvent evaporation technique. Pharm. Res. 1993;10:362-8.
23. Sah HK, Chien YW. Evaluation of a microreservoir-type biodegradable microcapsule for controlled release of proteins. Drug Dev. Ind. Pharm. 1993;19:1243-63.
24. Park TG, Lu W, Crotts G. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(D,L-lactic-co-glycolic acid) microspheres. J. Control. Release 1995;33:211-22.
25. Cleland JL, Powell MF, Shire SJ. The development of stable protein formulations: A close look at protein aggregation, deamidation and oxidation. CRC Crit. Rev. Therap. Drug Carrier Syst. 1993;10:307-77.
26. Charman SA, Mason KL, Charman WN. Techniques for assessing the effects of pharmaceutical excipients on the aggregation of porcine growth hormone. Pharm. Res. 1993;10:954-62.
27. Sluzky V, Tamada JA, Klibanov AM, Langer R. Kinetics of insulin aggregation in the presence of hydrophobic surfaces. Proc. Nati. Acad. Sci. USA 1991;88:9377-81.
28. Alonso MJ, Gupta RK, Siber GR, Langer R. Biodegradable microspheres as controlled release tetanus toxoid delivery systems. Vaccine 1994;12:299-306.
29. Sah HK, Toddywala R, Chien YW. Biodegradable microcapsules prepared by a W/O/W technique: effects of shear force to make primary W/O emulsion on their morphology and protein release. J. Microencapsulation 1995;12:59-69.
30. Yan C, Rill WL, Mall IR, Hewetson J, Tammariello R, Kende M. Dependence of ricin toxoid vaccine efficacy on the structure of poly(lactide-co-glycolide) carriers. Vaccine 1995;13:645-51.
31. Izutsu K, Yoshioka S, Kojima S. Increased stabilizing effects of amphiphilic excipients on freeze-drying of lactate dehydrogenase (LDH) by dispersion in sugar matrices. Pharm. Res. 1995;12:838-43.
32. Brewster ME, Hora MS, Simpkins JW, Bodor N. Use of 2-hydroxypropyl-β-cyclodextrin as a solubilizing and stabilizing excipient for protein drugs. Pharm. Res. 1991;8:792-5.
33. Matsuyama K, El-Gizway S, Perrin JH. Thermodynamics of binding of aromatic amino acids to α-, β, and γ-cyclodextrins. Drug Dev. Ind. Pharm. 1987;13:2687-91.
34. Uchida T, Yagi A, Oda Y, Nakada Y, Goto S. Instability of bovine insuline in poly(lactide-co-glycolide) microspheres. Chem. Pharm. Bull. 1996;44:235-6.